Daily Archives: June 20, 2020

Really Pathetic: First Amendment Expert Torches DOJ Efforts to Stop John Bolton Book – Law & Crime

Posted: June 20, 2020 at 11:10 am

First Amendment attorney Floyd Abrams on Friday savaged as pathetic the Department of Justices (DOJ) attempt to secure a temporary restraining order against the publication of John Boltons embarrassing book about the Trump White House.

What do you make of the governments argument that the Bolton book should be not published even though it has been written and shipped and all sorts of reporters have it [and] excerpts have appeared? guest host Brian Ross asked during a segment of The Dan Abrams Show on SiriusXM. (Floyd Abrams is the father of Law&Crime founder Dan Abrams.)

To which the elder Abrams replied:

I really think its just a nonstarter as a legal argument. Its one thing for the government to make claims that Mr. Bolton has violated his obligationsI dont think thats a strong claim but thats a claimbut to say that, in a situation where the books already out, where its around the world, where Simon & Schuster sent it to lots of people, where the press has it and is reporting on itthe notion of asking a judge to enter into order which cannot be enforced, effectively, cant be enforced because he cant give the relief the government wants in a meaningful sense.

The DOJ argued in a telephonic hearing on Friday that their request for an injunction should apply to Bolton and other third parties, which could include his publisher, book distributors, and possibly even retail stores. That position strained the bounds of legal credulity for various reasons, of course, but one of Attorney General Bill Barrs subordinates made it anyway.

The book is out, so the idea of [telling the judge to] enter an order in effect saying: Well, no more books, is a meaningless effort, Abrams noted. And particularly because what theyre seeking is a prior restraint, an injunction, a bar on publication. Thats the hardest thing to get of all. Its what the First Amendment most clearly protects against.

Abrams is well-positioned to elucidate on the prior restraint standard; he argued the successful landmark case before the Supreme Court which ultimately established it.

In New York Times v. United States, Abrams represented the newspaper against the Nixon administration in a watershed victory for freedom of speech. The case itself had to do with the publication of the Pentagon Papers leaked by Daniel Ellsberg which showed various U.S. presidents had lied to the public about the basis and progress of Americas police action in Vietnam.

Thats what the Pentagon Papers Case was aboutand lots of other casesmaking it clear, Abrams continued, noting the almost impossible barrier the government must meet when it attempts to censor a publication. It might be possible, but the government has to show terrible harm, and it has to be sure that the harm would occur, and theres no other way to deal with it.

Boltons attorney, Charles J. Cooper, naturally cited to the case Abrams won in a 175-page legal document dropped late Thursday night in his case.Any system of prior restraints of expression comes to th[e] Court bearing a heavy presumption against its constitutional validity, Cooper wrote, quoting and citing the courts opinion in New York Times.

Abrams went on to say that the U.S. vs. Bolton situation as a legal matter seems to be a futile and self-defeating effort by the government and one which cannot and I believe will not be granted.

So, why would they make such an obviously pointless request you think? Ross quizzed the nations most famous First Amendment attorney. Whats the strategy?

Again, Abrams had nothing but contempt for that legal effort:

I can only conclude its not strategy, but its the president. That he told them to do everything: Fire whatever atomic bombs youve got of a legal nature. And someone was unwilling to say no, so theyre going in on that to show how strong they are and how much they care [about what the president says], etcetera, etcetera, because, as a legal claim, its really pathetic.

[image via Alex Wong/Getty Images]

Have a tip we should know? [emailprotected]

Read more from the original source:
Really Pathetic: First Amendment Expert Torches DOJ Efforts to Stop John Bolton Book - Law & Crime

Posted in First Amendment | Comments Off on Really Pathetic: First Amendment Expert Torches DOJ Efforts to Stop John Bolton Book – Law & Crime

Revive Therapeutics betting on psychedelics and potential COVID-19 treatment Bucillamine – Proactive Investors USA & Canada

Posted: at 11:10 am

The company is filing an Investigational New Drug application with the FDA for the Phase 3 confirmatory clinical trial of Bucillamine

Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF) has come a long way in just six months under the stewardship ofCEOMichael Frank.That much is apparent from a casual glance at the share price for the year to date.

However, there is an argument to be made that suggests this may just be the start of the journey for this US and Canadian-listed life sciences innovator. For not only does Revive have a (coronavirus) COVID-19possible treatment headedtowards phase III clinical trials, but it also has some unique and interesting intellectual property (IP) that taps into the emerging area of psychedelics.

Also part of the story, but taking a back-seat for now, is its research around the potential uses of cannabidiol (CBD) to treat auto-immune hepatitis, ischemia and reperfusion injury from organ transplantation.

READ:Revive Therapeutics holds pre-CTA meeting with Health Canada for Bucillamine to treat COVID-19 patients

Revivehas a history of repurposing drugs and IP such asBucillamine,a cysteine derivativeanti-inflammatory that has been used for more than 30 years to treatrheumatoid arthritisin Japan and South Korea.

With an impeccable track record for safety, the companys researchers were assessingthe data fromits potential deployment in acute gout flareswhere ithad successfully completed a phase IIUS Food and Drug Administration (FDA)clinical trial.

Thats when more thoughts were given to the use of Bucillamine to treat lung inflammation.

The drug works by helping restore and enhance an antioxidant called glutathione. Revives team soon realized the same anti-inflammatory action that worked in gout and arthritis could possibly be deployed in people suffering lung inflammation as a result of seasonal flu, H1N1, SARS and, crucially, COVID-19.

In April, it applied to the US regulator to carry out a phase II trial in COVID-19and was surprised by the response.

BasedonBucillamines composition, efficacy, safety and history, as well as a previous, successful interaction with the FDA, the drugs watchdog asked Revive to prepare anInvestigational New Drug (IND) submissionfor a phase IIIconfirmatory trialin COVID-19.

Thats a very large milestone and a major study, says Frank.It gives the company a great deal of credibility.

The company is currently incorporating guidance provided by the US regulator intoits INDpackage, which should beready and submittedby the end of the month,Frank adds.

Another development that is exciting investors is the companys move into psychedelics, which appears incredibly well-timed.

Last year the FDA approvedesketamine to treat depression, making it the first-ever psychedelic drug to receive the regulatory green light in the US, with UK authorities giving their approval for the ketamine-like drug a few months later.

MDMA, meanwhile, has been given breakthrough therapy designation by the US regulator for post-traumatic stress disorder (PTSD), as has psilocybin, the psychoactive found in mushrooms, which is being developed as an alternative to traditional antidepressants.

In March, Revive announcedit was acquiring Psilocin Pharma Corp in an all-paper deal worth $2.75 million. Its focus is psilocybin-based treatments forvariousmedical needs, which includes rare and orphan indications.

Reviveis working with the University of Wisconsin on some new delivery technology that could add another dimension to the research and discoveries to date.

We want to build a better product, with more favorable onset and delivery of psilocybin and then move it down the clinical path, says Frank.

And thats crucial, because like many others in this new and flourishing area of drug discovery, the plan is to formally follow the highly regulated route to market.

In doing so the potential reward could be significant. The psychedelics industry itself is big enough to pique the interest of Big Pharma, with investment bank Canaccord Genuity, in a recent market report,estimating the total market size for all indications under investigation to be as much as $100 billion.

However, the smaller, more innovative players such as Revive, are likely toset the pace and make an impact.

Psychedelics have shown promising efficacy across a broad range of both mental and substance abuse disorders, said Canaccord inits report. Together, the targeted indications affect over one-billion people globally.

Frankstated:I think we have only scratched the surfacein a number of areas, and our team looks forward to educating the market more.

Contact the author Uttara Choudhury at[emailprotected]

Follow her onTwitter:@UttaraProactive

Read more:

Revive Therapeutics betting on psychedelics and potential COVID-19 treatment Bucillamine - Proactive Investors USA & Canada

Posted in Psychedelics | Comments Off on Revive Therapeutics betting on psychedelics and potential COVID-19 treatment Bucillamine – Proactive Investors USA & Canada

These Psychedelic Drugs May Be Key to Revolutionizing Weight Loss Treatment – Yahoo Finance

Posted: at 11:10 am

Houston, Texas--(Newsfile Corp. - June 19, 2020) - The global obesity epidemic is only growing in size.

"New federal data show that the obesity rate in the U.S. has hit 42.4%, up from 30.5% in 1999-2000," according to The Wall Street Journal. Worse, according to the World Health Organization (WHO) obesity has tripled in size over the last 50 years.

By 2030, almost half of U.S. adults will be considered obese.

Unfortunately, with obesity comes issues such as heart disease, stroke, type 2 diabetes, and several types of cancer. Even worse, according to Energy Balance and Obesity: What are the Main Drivers? "There is convincing evidence for a role of obesity as a causal factor for many types of cancer including colorectum, endometrium, kidney, oesophagus, postmenopausal breast, gallbladder, pancreas, gastric cardia, liver, ovary, thyroid, meningioma, multiple myeloma, and prostate cancers."

However, a solution may be found in psychedelics such as DMT and psilocybin, both of which activate serotonin receptors, or "nature's own appetite suppressant," as noted by Psychology Today. "This powerful brain chemical curbs cravings and shuts off appetite. It makes you feel satisfied even if your stomach is not full. The result is eating less and losing weight."

Psychedelics, Like DMT Could Help Treat Eating Disorders

The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) announced that its majority owned subsidiary NeonMind has filed an additional provisional patent application related to using psychedelics as medicine. The most recent patent application, filed on June 17, 2020 covers the administration of DMT to treat compulsive eating disorder and other illnesses.

DMT, or N,N-Dimethyltryptamine, is a derivative and structural analog of tryptamine, known for its hallucinogenic properties. It currently has no approved medical use, though DMT-containing plants are commonly used in indigenous Amazonian shamanic practice, and are sometimes found in the drink ayahuasca. DMT is found naturally in several plants including Mimosa tenuiflora, Diplopterys cabrerana, and Psychotria viridis. It is structurally similar to psilocin and its precursor psilocybin, a chemical found in so-called "magic mushrooms."

"DMT is a very interesting molecule that acts on the same type of serotonin receptors which are known to regulate appetite," says Dr. William Panenka, Chair of the NeonMind Scientific Advisory Board. "As part of our overall patent strategy, we are establishing defensible intellectual property around multiple compounds that act on these receptors and intend to follow this with rigorous clinical trial work to establish efficacy."

Psilocybin May be Key to Treating Obesity

NeonMind also filed a U.S. provisional patent application in the U.S. for the invention relating to therapeutic administration of psilocybin or psilocin, combined with supportive therapeutic treatment for a patient to provide weight loss benefits and treatment for related health issues.

The provisional patent is for a proposed guided psychedelic psilocybin therapy protocol using psychotherapy prior to, during and after the psychoactive effects of the Psilocybin are felt by the patient. The psychedelic assisted psychotherapy is designed to assist in gaining insights from positive psychedelic experiences, to be integrated into everyday life and to help plan, prepare and make sense of psychedelic experiences for a therapeutic result.

In addition, NeonMind has retained contract research organization Translational Life Sciences Inc. to design and plan an initial preclinical study using psilocybin which is anticipated to begin in the fall of 2020. The preclinical study is anticipated to provide data to design phase 2 human clinical trials to test Psilocybin as a weight loss treatment. The phase 2 clinical trials are anticipated to begin in 2021, subject to receiving all required regulatory approvals.

For more information, visit the company's website at https://yieldgrowth.com.

About MarijuanaStox

MarijuanaStox.com is a leading web destination for all cannabis related companies. Investors can also find current marijuana-related quality financial, medical, legal and social news. MarijuanaStox.com is a media agency in North America dedicated to the cannabis industry, helping companies that operate in the space to attract quality investors, working capital and real publicity. Since 2005, we have had public companies in the US and Canada have rely on us to grow and succeed.

Story continues

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with http://www.MarijuanaStox.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with http://www.MarijuanaStox.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of MarijuanaStox.com) and The Yield Growth Corp, Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer.

Contact Information:2818047972ty@marijuanastox.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/58207

Link:

These Psychedelic Drugs May Be Key to Revolutionizing Weight Loss Treatment - Yahoo Finance

Posted in Psychedelics | Comments Off on These Psychedelic Drugs May Be Key to Revolutionizing Weight Loss Treatment – Yahoo Finance

Champignon Brands CEO Dr Roger McIntyre authors studies appearing in two leading scientific journals – Proactive Investors USA & Canada

Posted: at 11:09 am

The articles, looking at safety and efficacy of ketamine as a mental health therapy, were co-authored in conjunction with the Canadian Rapid Treatment Centre of Excellence

Champignon Brands Inc (CSE:SHRM) (OTCQB:SHRMF) said its CEO Dr Roger McIntyre and the Canadian Rapid Treatment Centre of Excellence (CRTCE) have authored two articles on the safety and efficacy of ketamine in major peer-reviewed journals.

The research-driven company studies psilocybin and other psychedelics as treatments for mental health conditions and addiction disorders.

The first article, Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: Results from the Canadian rapid treatment center of excellence, was published in Expert Opinion on Drug Safetys latest edition.

Another study, The Effectiveness of Ketamine on Anxiety, Irritability, and Agitation: Implications for Treating Mixed Features in Adults with Major Depressive or Bipolar Disorder, appeared in the journal Bipolar Disorders.

McIntyre is a widely-renowned researcher on depression and founded the CRTCE, the first facility in Canada to provide rapid onset treatments for people with mood disorders.

The publications of data as it relates to ketamine treatment at the CRTCE continues to demonstrate the rapid and robust efficacy of ketamine in persons with depression and related disorders, Champignons CEO said in a statement.

Our data, for the first time in the field of psychiatry, shows that ketamine can improve a persons ability to function in their role and return to work within a few weeks. The significant efficacy of ketamine at our centre is also matched by stable side-effect profiles, as well as the acceptability of ketamine in people who are benefitting from this novel treatment, he added.

Champignon specializes in the formulation of a suite of medicinal mushrooms health products as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries.

Contact Angela at [emailprotected]

Follow her on Twitter @AHarmantas

Read the original post:

Champignon Brands CEO Dr Roger McIntyre authors studies appearing in two leading scientific journals - Proactive Investors USA & Canada

Posted in Psychedelics | Comments Off on Champignon Brands CEO Dr Roger McIntyre authors studies appearing in two leading scientific journals – Proactive Investors USA & Canada

Buy CBD Oil products Official shop

Posted: at 11:08 am

Posted on January 5, 2020 at 11:38 AM

Cannabidiol oil is classified as a Schedule I substance. There are currently several DEA-approved medical uses for cannabis. In fact, more than 85 percent of U.S. states have authorized the medical use of cannabis.

The DEA has classified cannabis as a Schedule I drug, meaning that the agency views it as having no medicinal value and low potential for abuse. The Schedule I classification means that DEA is prohibited from conducting research on cannabis and cannot include it in a list of drugs that may be prescribed to treat diseasesCannabidiol oil (CBD) has a wide variety of pharmacological effects. Although there have been many reports on CBD from the literature, there is still a paucity of research on its properties and interactions with the cannabinoid receptor system.

Despite the fact that hundreds of strains of Cannabis are cultivated around the world, the identity of the chemical compounds involved in marijuana psychoactivity remains largely unknown. The diverse presence of different phytocannabinoids and the unique set of molecular mechanisms mediating their effects on the brain complicate the identification of the main components of marijuana. CBD, the principal constituent of Cannabis, shows prominent biological activity in brain areas of the central nervous system and central nervous system depression disorders.

Cannabidiol oil has shown synergistic effects with marijuana in preclinical studies. That means CBD oil can be combined with tetrahydrocannabinol (THC), the psychoactive component of marijuana. These type of studies are also being done with THC-treated rats.

Some of the most interesting data has been produced in mice. The investigators found CBD and THC could produce synergistic effects on driving, which is important because some studies have shown that long-term driving impairment increases with chronic marijuana use. The dose-dependent effect of THC and CBD was surprising, because studies have shown THC has little to no effect on mice driving behavior.

Super way to weight loss for month. A month of training and you will lose 10 pounds. Checked by medics

Read more:

Buy CBD Oil products Official shop

Posted in Cbd Oil | Comments Off on Buy CBD Oil products Official shop

For Minneapolis CBD products maker, a pivotal change in strategy happened at pivotal time – Minneapolis Star Tribune

Posted: at 11:08 am

Kara Soule and her brothers Kirk and Travis grew up on an organic farm near Northfield with an appreciation for farmers who paid attention to quality and the distributors who got their food to consumers.

Three years ago, Kara used CBD oil to overcome a health challenge and, noticing that quality and pricing varied widely in the nascent industry, spotted an opportunity. She and her two older brothers, all with experience at large companies, decided to start their CBD products firm, called Verdant, as side gigs.

Eventually, Kara began working on the venture full time. Their plan to stand out was to focus on ingredient quality. But as they made the circuit of co-ops and outdoor events in the state, they heard one thing over and over: CBD products were too expensive.

After six months of debate, the siblings in February, changed strategy to focus on ultralow prices and direct distribution from their website. That meant giving up short-term profitability and, for Kara, a salary.

In an interview, they described why they did it and what happened as the pandemic hit. Some excerpts:

Q: How did you come up with the strategy?

Kara: We thought of two options. In order to reduce prices, we could reduce our ingredient quality. Often, youll see some companies CBD products with 4% CBD oil in them, something very diluted. Or the other option is to cut out our margins. Instead of compromising on quality, we chose to pull out all the profit margin, the retailer markup, any extra overhead. In fact, I am even not taking a salary. This is a missional company for us. We wanted to come to a place where we could provide really excellent products even if that cost us profit. Its our decision to permanently keep these products at cost.

Q: Can you describe the debates you had about this?

Kara: As siblings, theres always going to be discussion points. But there was never a question we would compromise on quality. Thats not who we are and not what we created this business to do. It really was inspired by the conversations we had with people around the state. We have done demos at local co-ops. Thats where the CBD market has been taking hold.

Travis: We met a lot of people who could take advantage of this and felt these products could change their lives in a meaningful way. We were touched by those conversations even though it goes against every business bone in our body. We felt like the need was too real. We terminated retail relationships, and we spent a year building up. It is a grand experiment, but we feel theres a real benefit to our community and our customers. And because we dont have outside investors, we can do what we want.

Kirk: We also did a small quantitative study just to evaluate what we were seeing. It was not just a self-selected group. Its a national trend. Its a national need. We used a third-party provider to assess what would keep people from using CBD products more often. There were a number of points of feedback. The one that resoundingly came back was 60% would use it more but it is still too expensive.

Q: What is the early effect of the pricing change?

Kara: We have seen a significant increase in our sales.

Kirk: It is scary to go from making a profit to not making a profit. But it has been very satisfying to be able to see the difference were making with customers.

Q: You made this change and then the coronavirus hit and now recession. What else did you have to do?

Kara: Were taking every precaution to make sure our product maintains its high quality and good supply. On a broader level, were sensitive to the difficult circumstances that many Minnesotans are dealing with. We hope by offering these products at a much lower cost that, even in these more difficult times when anxiety and stress is at a high, these products can help.

View original post here:

For Minneapolis CBD products maker, a pivotal change in strategy happened at pivotal time - Minneapolis Star Tribune

Posted in Cbd Oil | Comments Off on For Minneapolis CBD products maker, a pivotal change in strategy happened at pivotal time – Minneapolis Star Tribune

Penguin CBD Review: How Their Gummies, Oils And CBD Cream Helped Me Become My Best Self – BroBible

Posted: at 11:08 am

Presented in partnership with Penguin CBD

As anyone who has ever tried a CBD product knows, its hard to pinpoint exactly what makes one brand better than the other. They all tout themselves as being pure and tasty and effective, but what matters most are the results after trying them, with consistency being the most crucial differentiator.

Given the fact Ive used Penguin CBD products for the past few months, its easy to see how my entire life has been more productive, improving my overall mood and healthiness. Lets face it, thats not usually the revelation given the uncertain and stressful times were all going through.

SHOP PENGUIN CBD NOW

So how has Penguin CBD been so impactful on me these past few months? Simple: Because their products work as designed.

Whether Im popping a Penguin CBD gummy before bedtime to help me relax from my day, or rubbing the CBD cream on my face to help my skin look healthy and moisturized, to using a few drops of tincture as recovery on my joints after my long runs, theres no denying that the products have brought a certain calmness on the hecticness thats been going on.

And, while its easy to voice my positive experiences with Penguin CBD products, the devils always in the details when it comes to finding the best CBD products on the market, and Penguin sure as hell backs it up with their entire process.

SHOP PENGUIN CBD NOW

For those on the hunt to find the best CBD oil, best CBD gummies, or best CBD cream, take a look below at what makes Penguin CBD the go-to source to help with what youre looking for.

SHOP PENGUIN CBD NOW

SHOP PENGUIN CBD NOW

With Penguin CBD also available in CBD capsules which I have yet to try, but for sure have on my list to do so soon there are tons of different ways to receive the many benefits of CBD through your preferred way. So, whether its for one of the reasons Ive used these products for, or for other ways youre looking to improve things in your life, Penguin CBD products are the choice to go with for a consistent, pure experience each time.

SHOP PENGUIN CBD NOW

SHOP PENGUIN CBD NOW

The BroBible team writes about gear that we think you want. Occasionally, we write about items that are a part of one of our affiliate partnerships and we will get a percentage of the revenue from sales.

Link:

Penguin CBD Review: How Their Gummies, Oils And CBD Cream Helped Me Become My Best Self - BroBible

Posted in Cbd Oil | Comments Off on Penguin CBD Review: How Their Gummies, Oils And CBD Cream Helped Me Become My Best Self – BroBible

Global CBD Hemp Oil Market 2020-2027 Business Insights and Sustainable Growth in Respective Industry – Surfacing Magazine

Posted: at 11:08 am

Global CBD Hemp Oil Market 2020features key points about market share, new developments, and product analysis, market players, analysis of opportunities. According to the globalCBD Hemp Oilmarket report, major advancements and capacity development are driving the worldwide market. Made by using integrated approaches, this report is divided by company, by country, and by application/types for the competitive landscape analysis. The markets boom and developments are studied and an in-depth review is been given. It displays trends, drivers, and challenges of the market. Market share analysis and key trend analysis are the major accomplishing factors of this market document.

NOTE: This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-depth analysis of GlobalCBD Hemp OilMarket.

DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/411566/request-sample

Scope of GlobalCBD Hemp OilMarket:

The report is confident in providing an inclusive point of view on the market to those who are involved in the globalCBD Hemp Oilindustry or interested to enter. The report gives you knowledge about segmented by applications, product types, and major players. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.

Furthermore, the survey in the report focuses on product specifications, costs, production capacities, marketing channels, and market players. Upstream raw materials, downstream demand analysis, and a list of end-user industries have been studied, along with the suppliers in this market. The product flow and distribution channel have also been presented in this research report. The competitive landscape of the globalCBD Hemp Oilmarket consists of several global and regional players.

Some are the key players taken under coverage for this study are:Medical Marijuana, Elixinol, Canopy Growth Corporation, ENDOCA, Isodiol, and among others.

By regions, this report splits the globalCBD Hemp Oilmarket into several key regions, with sales, revenue, price, and gross margin market share of top players in these regions, like:North America, Europe, Asia Pacific, South America, and the Middle East and Africa.

BROWSE COMPLETE REPORT AND TABLE OF CONTENTS:https://www.fiormarkets.com/report/cbd-hemp-oil-market-by-type-pure-cbd-411566.html

Key Benefits of Purchasing This Report:

The study provides an in-depth analysis of the globalCBD Hemp Oilmarket with current and future trends. Current and future trends are outlined to determine the overall attractiveness of profitable trends to gain a stronger foothold in the market. Drivers and opportunities are evaluated to highlight the top factors responsible for market growth. Value chain analysis in the report gives a clear understating of the roles of stakeholders involved in the value chain. The report also incorporates information such as economic scenarios, benefits, limits, trends, market growth rates, figures, and SWOT analysis.

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@fiormarkets.com), who will ensure that you get a report that suits your needs.

Follow this link:

Global CBD Hemp Oil Market 2020-2027 Business Insights and Sustainable Growth in Respective Industry - Surfacing Magazine

Posted in Cbd Oil | Comments Off on Global CBD Hemp Oil Market 2020-2027 Business Insights and Sustainable Growth in Respective Industry – Surfacing Magazine

Unchurched: Tickling Evangelical Ears for 25+ Years | Roll to Disbelieve: Reaching Outside the Bubble – Patheos

Posted: at 11:07 am

Hi and welcome back! Today, we return to Lee Strobels 1993 bookInside the Mind of Unchurched Harry and Mary. In this book, Lee Strobel seeks to show evangelicals what people outside their insular bubble are like so they can better sell them membership in evangelical churches. Today, I want to show you the context of Unchurcheds earliest years what Christians then were like, and why they continue to read and love this book today.

(Previous Lee Strobel listicle posts: This Books Endorsements Reveal A Story;The Many Lies Lee Strobel Tells About Unchurched Harry and Mary;A Portrait of the Captain as a Young Hell-Bound Pagan (1-4);Indoctrinating Evangelicals More (5-8);Seeker-Sensitive Churches Ahoy (9-12);Martyrbation Ahoy (13-15);The Original Listicle and Comments.)

Lee Strobel is a stone-cold authoritarian. However, hes one who managed to scrabble himself to a position of relative power within his tribe. Thus, evangelical flocks look to him for information about their out-groups and to teach them how to sell their product (active membership in their groups) to these strange, alien, unknowable, unguessable, inscrutable Others.

And in 1993, yall, they werereallyOthers.

Something to remember about 1993 is that very few evangelicals probably actually knew anyunchurchedpeople going by the classic definition of people whove checked completely out of church culture or never joined it. At most, theyd likely have known people who missed church sometimes (or even often), or actively attended otherchurches. Obviously, evangelicals considered that latter groupthe wrong flavor of Christian. But those arent reallyunchurched people.

When I was evangelical myself, I sure didnt know any unchurched people until entering college at a state-funded university. Most of my friends attended various evangelical indoctrination-station colleges, so they wouldnt even have had that benefit. As well, the consumer internet wasnt anywhere near what it is now. Even as a very early adopter, I myself was barely online in the modern sense.

So in 1993, it was alotharder to find people who vocally rejected evangelicals product.

So in 1993, Lee Strobels book might actually have had a use if it hadnt been written by a schmoozer looking to pander to his eager audience.

Just as a start to explaining why its useless, his claims of having totally-been-an-atheist-yall were a lot harder to bust back then. After all, nobody outside the bubble would likely ever hear those claims, and nobody inside it had any idea that whatever Strobels version of atheism was, it sure doesnt look remotely like actual atheism from actual atheists. But his made-up fake testimony fed into what he teaches about unchurched people, and its definitely something he leans on hard to help his ideas sound more credible.

Second, evangelicals might as well be as isolated and alienated from their outgroup today as they were in the 1990s, or for that matter the Victorian era.

Nothing ever changes in their world. It cant.

As you can see from the above advertisement on his official Instagram, the huckster shilling this book still insists to this day that his work is valid and helpful. And the flocks always believe their hucksters. And really, gosh, yall, why would a Christian leader lie about anything so important?

Nowadays, evangelicals couldaskus what were like. Were not hard to find, and from all appearances we talk quite readily about our experiences and reasoningwhen its safe to do so. Weve filled entire websites multiple! with clearly-stated reasons for rejecting evangelicals product. Heres just one such site, and its got thousands of posts in it.

But evangelicals avoidinvestigating what we have to say about ourselves.

For one, their tribal leaders are busy slamming extimonies and deconstruction stories into the dirt, spinning them through the evangelical hatred machine, and trying their hardest to negate everything their newly-revealed enemies say.

Plus, theyre sure wed lie to their faces. After all, they do it all the time with Jesus own blessing apparently, and so they assume everyone else also lies constantly.

Perhaps worst of all, we heathens never, ever properly follow along with all the sales scripts their apologists have fed them over the past century or so.

(That was a problem for me in the 1990s. I didnt read apologetics books, but we got fed various scripts to use insoulwinning. These scripts used the same techniques, though, and they gave the same results.)

The sheer, misplaced trust that evangelicals consistently place in their apologists always blows my mind, even now. If they ever realized how much of the apologetics industry is pure cash-grabbing lies specifically engineered to divest them of their hard-earned cash and time and to keep them embedded in Christianity a little while longer, I mean like really realized it and saw that industry at last for what it is

I wonder what theyd do?

Over on Amazon, 70% of respondents bestowed 5 stars upon this book. Another 21% gave it 4 stars. The very few people rating it lower generally simply disagreed with Strobels doctrinal stances. None disagreed with his presentation of unchurched people generally.

Over on GoodReads, I see similar high praise. The few critics of the book noted that it felt dated, but I only saw one reviewer who noted that Strobels version of atheism doesnt look remotely like actual atheism.

A great many reviewers on both sites felt that Strobels own self-described conversion lent him more authority and credence in describing unchurched people. Because he describes himself as totally-once-an-atheist-you-guize, they trust him to accurately relay what atheism involves.

Every time I saw Christians gush with praise for the book, giving all this credit to Strobel for totally teaching them about the mindset of atheists, I died a little more inside.

They have no idea just how wrong he is. And they dont want to know, either.

However, I did find one review that made me laugh. Mostly, this person objected to Strobels crassly-commercialized view of church culture:

Strobel doesnt seem like so much an out-and-out con man as much as he seems like a shallow-minded, ambitious pragmatist.

And hey.

Hey.

Be reasonable here.

He could beboth.

As I skim through the beginning of Strobels book, it becomes readily apparent that he doesnt think anybody comes to atheism or disaffiliates from church for any reason hed consider valid. Nor does he want his readers to think theres any valid reason to reject their product.

Instead, in Strobel-Land unchurched people find themselves too busy for religion, or theyve had bad experiences that poisoned [their] attitude about Christianity. He accepts no other reasons for rejection.

Evangelicals have a consistent habit of expecting the rest of us to set ourselves on fire so they can keep warm. This approach works only in an atmosphere of Christian dominance. However, that dominance has eroded beyond repair. Maybe thats why so many Christians still eat up Lee Strobel books with a spoon.They yearn to feel dominant still, to be given permission to judge others and unilaterally decide to fix them.

Consistently in his book, Strobel spins stories about misunderstandings, lack of discernment, pique over mistreatment, and selfishness(as evangelicals weaponize the word) in unchurched people. In doing so, he teaches his readers techniques geared almost entirely toward ensuring their own retention. However, I can tell you right now that whatever his action plan involves, it doesnt work to persuade others.

Evangelicals dont care. Strobel tells them all the lies they ache to hear, and hes made huge bank with his pandering.

For years, evangelicals have loved what Lee Strobel tells them about their potential marks.

They love thinking that people dont reject them for valid reasons. In fact, Lee Strobel teaches them to judge those reasons and decide if theyre valid (pro-tip: those reasons never will be).

They love thinking that they can love people and yet treat them as human fix-it projects and more than that, like projects that they can adopt without permission and consent. Lee Strobel teaches them that their projects wont resent that at all.

Most of all, Lee Strobel teaches his readers evangelism tactics that he calls an action plan. He promises these gullible flocks that they can use his action plan to evangelize people who have either rejected their product or have spent a lifetime without it and thus dont need it.

As I said, I know already that whatever his plan is,it does not do what its seller claims it can do. If it did, Lee Strobels religion wouldnt be in terminal decline.

In fact, I bet it resembled in many ways how my own church taught us to evangelize in 1993. So thats where were setting sail for tomorrow, friends.

NEXT UP: Lets check out Lee Strobels action plan and compare it to Yr. Loyal &tc Captains experience as a Pentecostal in 1993. See you there!

Come join us onFacebook,Tumblr,Pinterest,Twitter, and our forum atrolltodisbelieve.com! (AlsoInstagram, where I mostly post cat pictures. About 99% of my insta consists of Bother being adorable.)

Also please check outour Graceful Atheist podcast interview!

Ifyou like what you see, I gratefully welcome your support. Please consider becoming one of my monthly patrons viaPatreon with Roll to Disbelievefor as little as $1/month! MyPayPal is captain_cassidy@yahoo.com(thats an underscore in there) for one-time tips. You can also support this blog throughmy Amazon Affiliate linkand, of course, by liking and sharing my posts on social media! This blog exists because of readers support, and I appreciate every single bit of it.

BTW: a future Lee Strobel post will involve his firm claim that some of his very best friends are atheists and apparently they are totes cool with him considering them his DIY projects for life.

Go here to read the rest:
Unchurched: Tickling Evangelical Ears for 25+ Years | Roll to Disbelieve: Reaching Outside the Bubble - Patheos

Posted in Atheism | Comments Off on Unchurched: Tickling Evangelical Ears for 25+ Years | Roll to Disbelieve: Reaching Outside the Bubble – Patheos

KOIOS nootropic beverages to be distributed through KeHE – food in canada

Posted: at 11:04 am

June 19, 2020, Vancouver, B.C. Koios Beverage Corp. has re-engaged with KeHE Distributors, a well-established national distributor of fresh, natural, organic and specialty food and beverage products with a network of more than 35,000 retail outlets across North America.

All five flavours of the companys KOIOS-branded functional nootropic beverages will be distributed through KeHE as part of its elevate program.

At the end of 2019, KeHE published a report with its predictions for the top five grocery industry trends for 2020, which included nootropics as a category experiencing growth based on an increased interest in supporting brain health.

Founded in 1952, KeHE is an employee-owned company that has more than 5,500 individuals across a network of 16 distribution centres in the United States and Canada, with a fleet of 500 trucks with daily routes from coast to coast. KeHE distributes more than 65,000 SKUs to the stores of its retail partners in North America, which include chain and independent grocers, mass merchandisers, convenience stores, and natural holistic pharmacies.

KeHE is also a certified B Corporation in good standing with B Lab, a body that measures companies entire social and environmental performance according to a rigorous set of standards. Fewer than 3,300 companies worldwide hold this certification.

KeHEs elevate program for emerging suppliers is intended to bring promising early-stage brands to KeHEs retail partners as a way of enhancing their brand portfolio.

We have always held KeHE in high regard as both an impressive distributor of natural and organic specialty products, and as an exemplary corporate citizen, said Koios CEO Chris Miller. Through its partnerships with Albertsons and Sprouts, in addition to numerous other retailers, their top-notch curation strategies and distribution network has earned them a footprint of more than 35,000 stores to which they distribute products.

We are very excited to be part of their elevate program in which Koios will benefit from the dedicated support of KeHEs category managers to drive the success of our products in the stores of their retail partners. We look forward to our continued partnership with KeHE to grow the profile of our KOIOS line of nootropic beverages.

Read this article:

KOIOS nootropic beverages to be distributed through KeHE - food in canada

Posted in Nootropics | Comments Off on KOIOS nootropic beverages to be distributed through KeHE – food in canada